MILPROSA

Peak

progesterone

NDAVAGINALSYSTEM
Approved
Apr 2020
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20

Clinical Trials (5)

NCT07461909N/ARecruiting

Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer

Started Nov 2024
400 enrolled
Frozen Embryo Transfer (FET)InfertilityArtificial Cycle+1 more
NCT05555121Phase 2Suspended

Rescue Progesterone Supplementation During Frozen Embryo Transfer

Started Dec 2022
150 enrolled
Fertility IssuesEmbryo ImplantationFrozen Embryo Transfer
NCT04549116Phase 3Active Not Recruiting

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.

Started Oct 2022
NCT05232344N/ACompleted

Sexual Intercourse and Vaginal Absorption of Progesterone

Started Apr 2022
40 enrolled
Infertility
NCT04682353Phase 1Completed

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

Started Dec 2020
60 enrolled
Contraception

Loss of Exclusivity

LOE Date
Jan 21, 2030
47 months away
Patent Expiry
Jan 21, 2030

Patent Records (3)

Patent #ExpiryTypeUse Code
10537584
Feb 3, 2029
Product
10548904
Feb 3, 2029
U-2810
8580293
Jan 21, 2030
U-2810